rituximab-alliinase conjugate

Preferred Label : rituximab-alliinase conjugate;

MeSH note : alliinase conjugated to the monoclonal antibody rituximab, which recognizes the CD20 antigen, and the resulting conjugate was targeted to CD20 B chronic lymphocytic leukemia (B-CLL) and other B-cell lymphomas;

Is substance : O;

Détails

Origin ID

C502340;

UMLS CUI

C1571288;

MeSH term(s) associated for indexing
- Rituximab [MeSH Descriptor]
- antibodies, monoclonal, Murine-Derived [MeSH Descriptor]
- carbon-sulfur lyases [MeSH Descriptor]
Record concept(s)
- rituximab-alliinase conjugate [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

All resources
or only the major
or use the search engine

recommendations
documents concerning education
documents for patients